Status:
COMPLETED
Effect of Dexmedetomidine on Hemodynamics in Cardiac Surgery
Lead Sponsor:
Pamukkale University
Conditions:
Use of Dexmedetomidine in Cardiac Surgery (CABG, Valve Replacement or Total Aortic Arch Replacement)
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
It is important to establish a stable haemodynamics in patients undergoing cardiac surgery. Haemodynamic depression is common during induction of anaesthesia \[1\]. Sympathetic response due to trachea...
Eligibility Criteria
Inclusion
- Patients over 18 years of age who underwent cardiovascular surgery (coronary artery bypass grafting, valve replacement or total aortic arch replacement) for ischaemic heart disease, valvular disease or aortic arch aneurysm were included.
Exclusion
- Severe cardiovascular disease \[(NYHA class 4 or left ventricular ejection fraction (LVEF) less than 30%)\] ,
- Concomitant systemic disorders (e.g. patients with severe liver dysfunction or chronic renal failure on haemodialysis),
- Pregnant women,
- Emergency cases
Key Trial Info
Start Date :
May 5 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 5 2022
Estimated Enrollment :
52 Patients enrolled
Trial Details
Trial ID
NCT06958913
Start Date
May 5 2022
End Date
November 5 2022
Last Update
May 6 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Pamukkale University
Denizli, Turkey (Türkiye), 20100